Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
If changing the injection day, ensure there are at least 48 hours between doses
Yet most patients were left to figure it out alone
Retatrutide Phase 2 Obesity Trial: Efficacy and Safety at 48 Weeks New England Journal of Medicine Phase 2 trial in 338 adults with obesity showed retatrutide 12 mg produced 24.2% body weight loss at 48 weeks the highest reported for any anti-obesity pharmacotherapy with manageable GI side effects
The SELECT trial with injected semaglutide demonstrated a 20% reduction in the frequency of 3-point MACE outcome in people with preexisting CVD and overweight/obesity without T2D [6], and injected semaglutide has been shown to reduce 3-point MACE outcomes by 26% in patients with pre-existing CVD and T2D [7]
Perkovic V, Jardine MJ, Neal B, et al
